SSA
FMTX

Schonfeld Strategic Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$8K – 3387
2022
Q3 		$8K Buy
+100,000
New +$1.32M ﹤0.01% 2740

Schonfeld Strategic Advisors's FMTX Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 546,891 shares — an estimated $10.9M sold.

Schonfeld Strategic Advisors first reported a position in FMTX in Q3 2020 and held it in 3 quarters. The position peaked at $10.9M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 546,891 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $10.9M.
  • Schonfeld Strategic Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $10.9M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.